{"disease":{"id":"refractory-cancer-pain","name":"refractory cancer pain"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07489625","title":"Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Qinghai Red Cross Hospital","has_results":false},{"nct_id":"NCT03362073","title":"Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":26,"lead_sponsor_name":"Pusan National University Yangsan Hospital","has_results":false},{"nct_id":"NCT04491123","title":"Intrathecal Analgesia Effects on Cancer Patients Discomfort Symptoms","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05561023","title":"Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":14,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}